Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 10, keine Gesamtzahl für „Table“
Suchtreffer
Begriffe & Kennungen
Borderline-Persönlichkeitsstörung
Eintrag öffnenBortezomib Accord · 4.8 · 20 Table 9: Incidence of peripheral neuropathy during induction treatment by toxicity and treatment discontinu
Eintrag öffnenBortezomib Accord · 4.8 · 53 Table 9: Incidence of peripheral neuropathy during induction treatment by toxicity and treatment discontinu
Eintrag öffnenBortezomib Accord · 4.8 · Notable differences in the safety profile of bortezomib administered subcutaneously versus intravenously as si
Eintrag öffnenBortezomib Accord · 4.8 · Notable differences in the safety profile of bortezomib administered subcutaneously versus intravenously as si
Eintrag öffnenBortezomib Accord · 4.8 · Table 10: Incidence of peripheral neuropathy in study LYM-3002 by toxicity and treatment discontinuation due t
Eintrag öffnenBortezomib Accord · 4.8 · Table 10: Incidence of peripheral neuropathy in study LYM-3002 by toxicity and treatment discontinuation due t
Eintrag öffnenBortezomib Accord · 4.8 · Table 7:Adverse reactions in patients with multiple myeloma treated with bortezomib in clinical studies, and a
Eintrag öffnenBortezomib Accord · 4.8 · Table 7:Adverse reactions in patients with multiple myeloma treated with bortezomib in clinical studies, and a
Eintrag öffnenBortezomib Accord · 4.8 · Table 8 Adverse reactions in patients with mantle cell lymphoma treated with BzR-CAP in a clinical study Syste
Eintrag öffnenBortezomib Accord · 4.8 · Table 8 Adverse reactions in patients with mantle cell lymphoma treated with BzR-CAP in a clinical study Syste
Eintrag öffnenBortezomib Accord · 4.8 · Tabulated list of adverse reactions Multiple myeloma Undesirable effects in Table 7 were considered by the inv
Eintrag öffnenBortezomib Accord · 4.8 · Tabulated list of adverse reactions Multiple myeloma Undesirable effects in Table 7 were considered by the inv
Eintrag öffnenBosulif · 4.8 · Table 4 – Adverse reactions for bosutinib
Eintrag öffnenBraftovi · 4.8 · Table 5: Adverse reactions Frequenc Encorafenib Encorafenib Encorafenib 300 mg in Encorafenib y single agent 4
Eintrag öffnenBridion · 4.8 · Table 2: Tabulated list of adverse reactions The safety of sugammadex has been evaluated in 3 519 unique subje
Eintrag öffnenBrilique · 4.8 · Bleeding Bleeding findings in PLATO Overall outcome of bleeding rates in the PLATO study are shown in Table 2.
Eintrag öffnenBrilique · 4.8 · Bleeding Bleeding findings in PLATO Overall outcome of bleeding rates in the PLATO study are shown in Table 2.
Eintrag öffnenBrilique · 4.8 · Bleeding Bleeding findings in PLATO Overall outcome of bleeding rates in the PLATO study are shown in Table 2.
Eintrag öffnenBrilique · 4.8 · Bleeding findings in PEGASUS Overall outcome of bleeding events in the PEGASUS study are shown in Table 3.
Eintrag öffnen